Which of the following mutants should not be used in an in vivo competition model (i.e., measuring competitive index between wild-type and mutant strains)?
a) Mutant A with reduced virulence.
b) Mutant B with increased antibiotic resistance.
c) Mutant C with impaired growth rate.
d) Mutant D with enhanced nutrient uptake.